Arrigo Francesco Giuseppe Cicero: Diagnostic and Prognostic Perspectives of Glycocalyx Disruption in Pregnancy
Arrigo Francesco Giuseppe Cicero, Head and Associate Professor of Human Nutrition at Alma Mater Studiorum – University of Bologna and President at SiNut Official, shared a post on LinkedIn about a recent article he and his colleges co-authored, adding:
“I’m pleased to share our latest publication in Inflammation Research:
‘Biomarkers of endothelial glycocalyx dysfunction in pregnancy: a systematic review of clinical relevance and detection techniques’
In this work, we explored the role of the endothelial glycocalyx as a key regulator of vascular homeostasis and its involvement in pregnancy-related complications such as preeclampsia.
Key insights:
- Glycocalyx disruption is consistently associated with adverse maternal–fetal outcomes
- Circulating biomarkers (e.g., syndecan-1, hyaluronic acid, heparan sulfate) may serve as indicators of endothelial injury
- Emerging imaging techniques could support early detection and risk stratification
These findings highlight the potential of integrating glycocalyx-related biomarkers into clinical practice, opening new perspectives for cardio-obstetric care.”
Title: Biomarkers of endothelial glycocalyx dysfunction in pregnancy: a systematic review of clinical relevance and detection techniques
Authors: Federica Fogacci, Duha Yahya, Jeanine Roeters Van Lennep, Katariina Öörni, Valentina Di Micoli, Francesco De Seta, Cristina Scollo, Claudio Borghi, Arrigo Francesco Giuseppe Cicero
Read the Full Article on Inflammation Research
Stay updated on all scientific advances with Hemostasis Today.
-
Sep 16, 2026, 16:06Katrina Louise Manalaysay: In Your 20s, You Might be Given the Opportunity to Donate Blood for the First Time
-
Sep 16, 2026, 15:45Matthew Hazell: A Brilliant Explanation of Phenotype vs Genotype Using a LEGO House
-
Sep 16, 2026, 15:23Ahmad Al-Ramahi: Presenting the Military Pharmacists Blood Training Course at the FIP World Congress
-
Sep 16, 2026, 15:21HIT Reimagined: Can 12-Lipoxygenase Inhibition Stop Immune Thrombosis?
-
Sep 16, 2026, 14:42Ruchi Punamia: Beyond the Blood Bank and The Clinical Impact of Apheresis
-
Sep 16, 2026, 14:06Kalyan Roy: Celebrating Apheresis, Advancing Care, Saving Lives
-
Sep 16, 2026, 13:38Andrew Zapfel: Advancing Sickle Cell Disease Care and Research
-
Sep 16, 2026, 13:30Thirunavukkarasu Angappan: Why Plasma-Derived Factor VIII Still Matters for Inhibitor Patients
-
Sep 16, 2026, 13:22Matthew Hazell: New BSH Guidance for Fetal, Neonatal and Paediatric Transfusion